| +0.395 / +3.20%|
The 2 analysts offering 12-month price forecasts for Vanda Pharmaceuticals Inc have a median target of 27.50, with a high estimate of 30.00 and a low estimate of 25.00. The median estimate represents a +115.60% increase from the last price of 12.76.
The current consensus among 2 polled investment analysts is to Buy stock in Vanda Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.